Chemotherapy-related hair loss is common, with about 65% of chemo patients losing their hair. However, hair loss is a harrowing event; according to studies, nearly half of female chemo patients consider it to be the most traumatic part of chemo. The profound impact of hair loss is known to strike... Read more »

Defendants Johnson & Johnson allegedly ignored the link between long-term talc powder use and ovarian cancer, claims a new joint lawsuit filed by 10 plaintiffs. The plaintiffs include six families of women who lost their lives to ovarian cancer that was allegedly caused by the long-term use of talc for... Read more »

Recent large scale epidemiological and retrospective studies have demonstrated links between the use of proton pump inhibitors (PPIs) and an increased risk of renal failure, myocardial infarction and dementia. On top of this, medical experts say that up to 70 percent of patients that take PPIs for treatment of heartburn... Read more »

The U.S. Food and Drug Administration has issued a new safety alert regarding the type 2 diabetes drug canagliflozin — Invokana and Invokamet. The Agency issued a safety announcement on May 18, notifying patients and the medical community that results of an ongoing clinical trial revealed a higher number of... Read more »

A judge in St. Louis, Missouri ordered Johnson & Johnson to pay plaintiff Gloria Ristesund $55 million in damages for allegedly “failing to warn consumers of known risks” associated with their talcum powder – the second verdict of its kind, to date. In February, the same court awarded $72 million to the... Read more »

Morning sickness is a common side effect of pregnancy. While mild morning sickness does not necessarily constitute a health risk, some parents are alleging that one treatment option for it might harm a developing baby. Two of these parents, who reside in Lafayette Parish, Louisiana, have filed a lawsuit against... Read more »

Xarelto, a highly touted alternative to the blood-thinning medication Warfarin, has come under fire with questions about the clinical trial that led to its approval. Faulty equipment used to monitor some of the patients in the trial may have contributed to results that made Xarelto look superior to warfarin, leading... Read more »

Fresenius Medical Care North America agreed to a $250 million settlement to resolve lawsuits that claim the company was aware of risks of their dialysis products yet failed to warn the public. The litigation centers upon Granuflo and Naturalyte, two dialysates that have been blamed for heart problems, strokes and death... Read more »

A Missouri jury has awarded $72 million to the family of a woman after determining her ovarian cancer was directly linked to decades of use of talcum powder products manufactured by Johnson & Johnson. The verdict was the first to award damages to a plaintiff after determining the pharmaceutical giant... Read more »

The Xarelto multidistrict litigation in Louisiana continues to grow, as another lawsuit was added to the ongoing proceedings on February 11. Estella Roethler filed a lawsuit individually and as the representative of the estate of Augustina Asocar Rodriguez. Rodriguez was prescribed and ingested the blood thinning medication from approximately January... Read more »